Colgate-Palmolive Company $CL Shares Bought by Federation des caisses Desjardins du Quebec

Key Points

• Federation des caisses Desjardins du Quebec increased its stake in Colgate-Palmolive Company by 19.4% during the 1st quarter, holding 385,391 shares worth approximately $36 million.
• Colgate-Palmolive reported a quarterly EPS of $0.92, beating expectations and achieving a net margin of 14.55% with revenues up 1% year-over-year.
• The company's recent dividend of $0.52 per share represents a 2.5% yield and a payout ratio of 58.43%.

Federation des caisses Desjardins du Quebec raised its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 19.4% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 385,391 shares of the company's stock after acquiring an additional 62,702 shares during the period. Federation des caisses Desjardins du Quebec's holdings in Colgate-Palmolive were worth $36,112,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the company. Personal CFO Solutions LLC purchased a new position in shares of Colgate-Palmolive during the first quarter worth approximately $285,000. Vision Capital Management Inc. purchased a new position in shares of Colgate-Palmolive during the first quarter worth approximately $322,000. Autumn Glory Partners LLC increased its position in shares of Colgate-Palmolive by 67.4% during the first quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock worth $851,000 after acquiring an additional 3,586 shares during the period. Financial Gravity Asset Management Inc. purchased a new position in shares of Colgate-Palmolive during the first quarter worth approximately $2,166,000. Finally, Penserra Capital Management LLC grew its holdings in Colgate-Palmolive by 398.6% during the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock worth $997,000 after acquiring an additional 8,515 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Up 1.7%

Shares of CL stock traded up $1.46 during trading hours on Friday, reaching $85.13. 6,165,415 shares of the stock were exchanged, compared to its average volume of 4,512,389. The firm has a market capitalization of $68.80 billion, a P/E ratio of 23.91, a P/E/G ratio of 4.43 and a beta of 0.35. Colgate-Palmolive Company has a 12-month low of $82.40 and a 12-month high of $109.04. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The business's fifty day moving average is $86.74 and its two-hundred day moving average is $89.77.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the prior year, the company earned $0.91 earnings per share. The company's revenue was up 1.0% compared to the same quarter last year. As a group, research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.4%. Colgate-Palmolive's payout ratio is 58.43%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a report on Monday, August 4th. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Citigroup decreased their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research note on Monday, August 4th. UBS Group cut their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Finally, Barclays boosted their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 15th. Seven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and an average price target of $98.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.